Dexmedetomidine

Generic Name
Dexmedetomidine
Brand Names
Dexdor, Igalmi, Precedex, Dexmedetomidine Accord
Drug Type
Small Molecule
Chemical Formula
C13H16N2
CAS Number
113775-47-6
Unique Ingredient Identifier
67VB76HONO
Background

An agonist of receptors, adrenergic alpha-2 that is used in veterinary medicine for its analgesic and sedative properties. It is the racemate of dexmedetomidine.

Indication

Administered intravenously, dexmedetomidine is indicated for the sedation of initially intubated and mechanically ventilated patients during treatment in intensive care settings, and for the sedation of non-intubated patients prior to and/or during surgery and other procedures. It is also available as a buccally- or sublingually-administered dissolvable film...

Associated Conditions
Agitation, Alcohol Withdrawal Syndrome
Associated Therapies
-

Dexmedetomidine in Seizure Patients

Phase 1
Completed
Conditions
First Posted Date
2010-05-05
Last Posted Date
2013-08-09
Lead Sponsor
University of California, San Francisco
Target Recruit Count
16
Registration Number
NCT01116700
Locations
🇺🇸

University of California San Francisco, San Francisco, California, United States

Dexmedetomidine Versus Midazolam for Intensive Care Sedation of Children

Phase 3
Conditions
Interventions
First Posted Date
2010-03-24
Last Posted Date
2011-07-21
Lead Sponsor
Ullevaal University Hospital
Target Recruit Count
40
Registration Number
NCT01091818
Locations
🇳🇴

Dept of Anesthesiology, Oslo University Hospital, Ullevaal, Oslo, Norway

Sedation to Electroencephalography With Dexmedetomidine or Chloral Hydrate

First Posted Date
2010-03-10
Last Posted Date
2013-10-25
Lead Sponsor
Federal University of Minas Gerais
Target Recruit Count
25
Registration Number
NCT01083797
Locations
🇧🇷

Santa Casa de Belo Horizonte, Belo Horizonte, Minas Gerais, Brazil

Effect of Dexmedetomidine on Gastric Emptying and Gastrointestinal Transit

First Posted Date
2010-03-10
Last Posted Date
2010-06-04
Lead Sponsor
University of Turku
Target Recruit Count
12
Registration Number
NCT01084473
Locations
🇫🇮

Department of Anaesthesiology, Intensive Care, Emergency Care and Pain Medicine, Turku University and Turku University Hospital, Turku, Finland

Dexmedetomidine-propofol-remifentanil Anaesthesia and Reactivity to Noxious Stimuli

Phase 4
Completed
Conditions
Interventions
First Posted Date
2010-02-26
Last Posted Date
2013-10-09
Lead Sponsor
Arvi Yli-Hankala
Target Recruit Count
44
Registration Number
NCT01076790
Locations
🇫🇮

Tampere University Hospital, Tampere, Finland

Dexmedetomidine Pharmacokinetics-pharmacodynamics in Mechanically Ventilated Children With Single-organ Respiratory Failure

Phase 3
Terminated
Conditions
First Posted Date
2010-02-26
Last Posted Date
2011-10-04
Lead Sponsor
University Hospital, Ghent
Target Recruit Count
1
Registration Number
NCT01076816
Locations
🇧🇪

University Hospital Ghent, Ghent, Belgium

🇧🇪

Cliniques Universitaires Saint-Luc, Brussels, Belgium

Sedation With Dexmedetomidine During Cardiac Catheterization

Phase 2
Terminated
Conditions
Interventions
First Posted Date
2010-02-22
Last Posted Date
2019-04-16
Lead Sponsor
Aruna Nathan
Target Recruit Count
4
Registration Number
NCT01072643
Locations
🇺🇸

The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States

Dexmedetomidine Versus Placebo in Endoscopic Retrograde Cholangiopancreatography (ERCP) Sedation

Phase 4
Completed
Conditions
Interventions
First Posted Date
2010-02-18
Last Posted Date
2012-07-16
Lead Sponsor
Helsinki University Central Hospital
Target Recruit Count
50
Registration Number
NCT01070680
Locations
🇫🇮

Helsinki University Central Hospital,Meilahti hospital,Endoscopy unit, Helsinki, Uusimaa, Finland

Comparison of Two Doses of Intranasal Dexmedetomidine as Premedication in Children

First Posted Date
2010-02-09
Last Posted Date
2017-10-26
Lead Sponsor
The University of Hong Kong
Target Recruit Count
104
Registration Number
NCT01065701
Locations
🇭🇰

QUeen Mary Hospital, Hong Kong, Hong Kong

Dexmedetomidine Versus Propofol in the Medical Intensive Care Unit (MICU)

First Posted Date
2010-02-01
Last Posted Date
2018-07-03
Lead Sponsor
University of Chicago
Target Recruit Count
41
Registration Number
NCT01059929
Locations
🇺🇸

The University of Chicago Medical Center, Chicago, Illinois, United States

© Copyright 2024. All Rights Reserved by MedPath